In an internal review that later became public, IBM’s Watson for Oncology was shown a patient much like thousands treated every day: a 65-year-old man with lung cancer who was also suffering from severe bleeding. The system recommended bevacizumab — a drug that carries an explicit warning against use in patients with severe hemorrhage, precisely […]
